LABTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Lakewood-Amedex Biotherapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.58+0.00 (+0.59%)
Close on Oct 19, 2026
- Market cap
- $828.29K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$72.9166 (−99.21%)since Apr 24, 2026
Weekly closes, adjusted for splits, on a log scale. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $828.29K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.19
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $3.05
- Diluted shares
- 1M
Two years at a glance
Fiscal years 2024 to 2025, USD
Reported period